Related references
Note: Only part of the references are listed.MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ
Jian Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma
Heng Xiao et al.
CANCER SCIENCE (2015)
Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor
Ivette Valencia-Sama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Functional and Clinical Evidence That TAZ is a Candidate Oncogene in Hepatocellular Carcinoma
Yan Guo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma
Samantha E. Hiemer et al.
MOLECULAR CANCER RESEARCH (2015)
The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer
Zhongwu Li et al.
MOLECULAR ONCOLOGY (2015)
Ski regulates Hippo and TAZ signaling to suppress breast cancer progression
Juliet Rashidian et al.
SCIENCE SIGNALING (2015)
Transcriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-β
Mei Wang et al.
ONCOTARGET (2015)
A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ
Guosheng Tan et al.
ONCOTARGET (2015)
Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib
Wei Xu et al.
CELL AND BIOSCIENCE (2015)
Transcriptional Co-repressor Function of the Hippo Pathway Transducers YAP and TAZ
Minchul Kim et al.
CELL REPORTS (2015)
Ski regulates Hippo and TAZ signaling to suppress breast cancer progression
Juliet Rashidian et al.
SCIENCE SIGNALING (2015)
The Transcriptional Regulators TAZ and YAP Direct Transforming Growth Factor β-induced Tumorigenic Phenotypes in Breast Cancer Cells
Samantha E. Hiemer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Impact of Chemoreduction for Conservative Therapy for Retinoblastoma in Argentina
Guillermo L. Chantada et al.
PEDIATRIC BLOOD & CANCER (2014)
Correction: Temporal Expression of Pelp1 during Proliferation and Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells
Jing Wang et al.
PLoS One (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death
Tero Kivela
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation
Tina Di Palma et al.
EXPERIMENTAL CELL RESEARCH (2009)
Basic understanding of current classification and management of retinoblastoma
Carol L. Shields et al.
CURRENT OPINION IN OPHTHALMOLOGY (2006)
A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome
M Murakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The retinoblastoma tumour suppressor in development and cancer
M Classon et al.
NATURE REVIEWS CANCER (2002)
Share Paper
